Competitor benchmarking and performance gap analysis for a leading European medical device player

  • Identified opportunities for expansion and plausible revenue streams

  • Identified potential geographies and activation levers from competitors

  • A leading European medical device player wanted to evaluate its competitive positioning relative to other major players’
  • Key challenges were :
    • Expanding its geographical footprint and product portfolio
    • Developing a roadmap for launching products in new and emerging-market segments
    • Identifying potential activation levers and competitors’ strategies
    • Identifying plausible challenges during expansion
  • Benchmarking competitors based on :
    • Operating segments
    • Geographical footprint – manufacturing and sales
    • Products and pipeline
    • Peer analysis and scoring
    • Collaboration and partnerships
    • Impact of competitors
  • Industry profiling based on :
    • Market size, industry growth
    • Trends, drivers and challenges
    • Country policies
    • M&A target screening
    • Regulatory research
  • Evaluated the company’s relative position in each therapeutic area and overall
  • Helped the company understand key opportunity areas and activation levers to unlock value
Thank you for sharing your details

Your file will start downloading automatically

If it does not download within 1 minute,

Share this on

What we have done

Opportunity assessment and market attractiveness for one of the top 10 pharmaceutical major
What we are proud of

Benchmarked therapeutic areas with high clinical and market potential

Developed potential market scenarios based on client needs

Assessing viability of entering the NSCLC market
What we are proud of

Evaluated unmet needs to identify potential entry points

Conducted a deep-dive study of key assets and key players

Supplier assessment and industry benchmarking for a global top 10 pharmaceutical company
What we are proud of

Optimised vendor-associated costs across geographies

Identified billing arrangements across law firms

Assessment of GCC pharmaceutical market for a global European pharma major
What we are proud of

Analysed potential for entry into the GCC pharmaceutical market

Assessed possible market drivers and barriers to entry

Product launch strategy for European biopharmaceutical company
What we are proud of

Identified geographical concentration of demand

Designed optimal distribution channel configuration

Research on a multiple sclerosis drug with help from global neurologists
What we are proud of

Assessed the target market size, key competitors and current pricing range

Enabled the client to take informed decisions thereby increasing market penetration

Patient treatment pathway analysis for venom allergies
What we are proud of

Increased customer/patient satisfaction and conversion rate

Gained a better understanding of stakeholders’ and patients’ behaviour along the pathway